206 related articles for article (PubMed ID: 23077718)
1. Click-modified cyclodextrins as nonviral vectors for neuronal siRNA delivery.
O'Mahony AM; Godinho BM; Ogier J; Devocelle M; Darcy R; Cryan JF; O'Driscoll CM
ACS Chem Neurosci; 2012 Oct; 3(10):744-52. PubMed ID: 23077718
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of cationic amphiphilic cyclodextrins for neuronal delivery of siRNA: effect of reversing primary and secondary face modifications.
O'Mahony AM; Doyle D; Darcy R; Cryan JF; O'Driscoll CM
Eur J Pharm Sci; 2012 Dec; 47(5):896-903. PubMed ID: 23022516
[TBL] [Abstract][Full Text] [Related]
3. In vitro investigations of the efficacy of cyclodextrin-siRNA complexes modified with lipid-PEG-Octaarginine: towards a formulation strategy for non-viral neuronal siRNA delivery.
O'Mahony AM; Desgranges S; Ogier J; Quinlan A; Devocelle M; Darcy R; Cryan JF; O'Driscoll CM
Pharm Res; 2013 Apr; 30(4):1086-98. PubMed ID: 23192687
[TBL] [Abstract][Full Text] [Related]
4. Self-assembling modified β-cyclodextrin nanoparticles as neuronal siRNA delivery vectors: focus on Huntington's disease.
Godinho BM; Ogier JR; Darcy R; O'Driscoll CM; Cryan JF
Mol Pharm; 2013 Feb; 10(2):640-9. PubMed ID: 23116281
[TBL] [Abstract][Full Text] [Related]
5. Structure-property relationship for in vitro siRNA delivery performance of cationic 2-hydroxypropyl-β-cyclodextrin: PEG-PPG-PEG polyrotaxane vectors.
Badwaik VD; Aicart E; Mondjinou YA; Johnson MA; Bowman VD; Thompson DH
Biomaterials; 2016 Apr; 84():86-98. PubMed ID: 26826298
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: in vitro analysis.
Gooding M; Malhotra M; McCarthy DJ; Godinho BM; Cryan JF; Darcy R; O'Driscoll CM
Eur J Pharm Sci; 2015 Apr; 71():80-92. PubMed ID: 25703259
[TBL] [Abstract][Full Text] [Related]
7. Early-stage development of novel cyclodextrin-siRNA nanocomplexes allows for successful postnebulization transfection of bronchial epithelial cells.
Hibbitts A; O'Mahony AM; Forde E; Nolan L; Ogier J; Desgranges S; Darcy R; MacLoughlin R; O'Driscoll CM; Cryan SA
J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):466-77. PubMed ID: 24665866
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable Polyester of Poly (Ethylene glycol)-sebacic Acid as a Backbone for β -Cyclodextrin-polyrotaxane: A Promising Gene Silencing Vector.
Ghodke S; Mahajan P; Gupta K; Ver Avadhani C; Dandekar P; Jain R
Curr Gene Ther; 2019; 19(4):274-287. PubMed ID: 31393245
[TBL] [Abstract][Full Text] [Related]
9. A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor.
Fitzgerald KA; Malhotra M; Gooding M; Sallas F; Evans JC; Darcy R; O'Driscoll CM
Int J Pharm; 2016 Feb; 499(1-2):131-145. PubMed ID: 26721726
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of hypoxia-induced proliferation of pulmonary arterial smooth muscle cells by a mTOR siRNA-loaded cyclodextrin nanovector.
Liu X; Wang G; You Z; Qian P; Chen H; Dou Y; Wei Z; Chen Y; Mao C; Zhang J
Biomaterials; 2014 May; 35(14):4401-16. PubMed ID: 24582377
[TBL] [Abstract][Full Text] [Related]
11. Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review.
Chaturvedi K; Ganguly K; Kulkarni AR; Kulkarni VH; Nadagouda MN; Rudzinski WE; Aminabhavi TM
Expert Opin Drug Deliv; 2011 Nov; 8(11):1455-68. PubMed ID: 21867463
[TBL] [Abstract][Full Text] [Related]
12. Cationic and PEGylated Amphiphilic Cyclodextrins: Co-Formulation Opportunities for Neuronal Sirna Delivery.
O'Mahony AM; Ogier J; Darcy R; Cryan JF; O'Driscoll CM
PLoS One; 2013; 8(6):e66413. PubMed ID: 23805220
[TBL] [Abstract][Full Text] [Related]
13. Tf-lipoplexes for neuronal siRNA delivery: a promising system to mediate gene silencing in the CNS.
Cardoso AL; Simões S; de Almeida LP; Plesnila N; Pedroso de Lima MC; Wagner E; Culmsee C
J Control Release; 2008 Dec; 132(2):113-23. PubMed ID: 18796321
[TBL] [Abstract][Full Text] [Related]
14. Pendant polymer:amino-β-cyclodextrin:siRNA guest:host nanoparticles as efficient vectors for gene silencing.
Kulkarni A; DeFrees K; Hyun SH; Thompson DH
J Am Chem Soc; 2012 May; 134(18):7596-9. PubMed ID: 22545899
[TBL] [Abstract][Full Text] [Related]
15. PEGylated cyclodextrins as novel siRNA nanosystems: correlations between polyethylene glycol length and nanoparticle stability.
Godinho BM; Ogier JR; Quinlan A; Darcy R; Griffin BT; Cryan JF; O'Driscoll CM
Int J Pharm; 2014 Oct; 473(1-2):105-12. PubMed ID: 24992319
[TBL] [Abstract][Full Text] [Related]
16. Non-viral vectors based on magnetoplexes, lipoplexes and polyplexes for VEGF gene delivery into central nervous system cells.
Villate-Beitia I; Puras G; Soto-Sánchez C; Agirre M; Ojeda E; Zarate J; Fernández E; Pedraz JL
Int J Pharm; 2017 Apr; 521(1-2):130-140. PubMed ID: 28185961
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain.
Kim ID; Lim CM; Kim JB; Nam HY; Nam K; Kim SW; Park JS; Lee JK
J Control Release; 2010 Mar; 142(3):422-30. PubMed ID: 19944723
[TBL] [Abstract][Full Text] [Related]
18. Cationic lipids and polymers mediated vectors for delivery of siRNA.
Zhang S; Zhao B; Jiang H; Wang B; Ma B
J Control Release; 2007 Oct; 123(1):1-10. PubMed ID: 17716771
[TBL] [Abstract][Full Text] [Related]
19. Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukemia: Physicochemical Characteristics, in Vitro Mechanistic Studies, and ex Vivo Patient Derived Therapeutic Efficacy.
Guo J; Russell EG; Darcy R; Cotter TG; McKenna SL; Cahill MR; O'Driscoll CM
Mol Pharm; 2017 Mar; 14(3):940-952. PubMed ID: 28146632
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyapatite nanoparticles modified by branched polyethylenimine are effective non-viral vectors for siRNA transfection of hepatoma cells in vitro.
Xu XL; Yang HY; Ou B; Lin SD; Wu H; He W; Jiang QC; Luo BM; Li GP
Int J Oncol; 2015 May; 46(5):2138-42. PubMed ID: 25760143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
